Masimo Corp. has responded to a lawsuit by an activist investor in a fight over board seats by asking a judge to validate the disclosure requirements it has imposed on anyone nominating directors.
The medical device company is being sued by Politan Capital Management over what the activist investor has called “draconian” amendments to its bylaws. Masimo filed a counterclaim Monday asking a Delaware Chancery Court judge to uphold the measures, saying they’re needed to ensure its shareholders are fully informed when they vote for directors.
“Politan is refusing to provide information about its significant financial backers and ‘sidecar vehicles’ ...
